The FDA accepted Achieve Life Sciences' investigational new drug application for cytisine as a treatment for smoking cessation. A late-stage trial of the drug is anticipated to start in the first half next year.
Achieve's IND for smoking cessation drug accepted by FDA
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.